K. Schellekens

发表

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Erik De Clercq, Jan Desmyter, Dominique Schols, 1990, Nature.

Bezitramide (R 4845), a new potent and orally long-acting analgesic compound.

C. Niemegeers, P. Janssen, W. Amery, 1971, Arzneimittel-Forschung.

The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to Haloperidol.

C. Niemegeers, P. Janssen, K. Schellekens, 1963, Arzneimittel-Forschung.

TIBO R82913, a new HIV-1 inhibiting agent, does not inhibit hematopoietic progenitor cells.

A. Ganser, K. Andries, O. Ottmann, 1991, AIDS research and human retroviruses.

Etomidate, R-(+)-ethyl-1-( -methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats.

C. Niemegeers, P. Janssen, K. Schellekens, 1971, Arzneimittel-Forschung.

The antiemetic effects of domperidone, a novel potent gastrokinetic.

C. Niemegeers, P. Janssen, K. Schellekens, 1980, Archives internationales de pharmacodynamie et de therapie.

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.

C. Niemegeers, P. Janssen, K. Schellekens, 1967, Arzneimittel-Forschung.

Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs.

C. Niemegeers, P. Janssen, K. Schellekens, 1976, Arzneimittel-Forschung.

Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-phenylpiperidino)butyrophenone. I. Synthesis and screening data in mice.

C. Niemegeers, P. Janssen, K. Schellekens, 1959, Journal of medicinal and pharmaceutical chemistry.

Tetramisole (R 8299), A New, Potent Broad Spectrum Anthelmintic

C. Niemegeers, P. Janssen, A. Raeymaekers, 1966, Nature.

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

C J Niemegeers, A. Megens, T. Meert, 1988, The Journal of pharmacology and experimental therapeutics.

Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.

C. Niemegeers, J. Heykants, K. Schellekens, 1978, Arzneimittel-Forschung.

Benzetimide and its optical isomers.

C. Niemegeers, P. Janssen, K. Schellekens, 1971, Arzneimittel-Forschung.

Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.

C. Niemegeers, P. Janssen, K. Schellekens, 1968, Arzneimittel-Forschung.

Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators

C. Niemegeers, K. Schellekens, M. Borgers, 1977, Experientia.

N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin.

C. Niemegeers, P. Janssen, K. Schellekens, 1976, Arzneimittel-Forschung.

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

C. Niemegeers, P. Janssen, K. Schellekens, 1965, Arzneimittel-Forschung.

Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).

A. Megens, T. Meert, C. Niemegeers, 1992, The Journal of pharmacology and experimental therapeutics.

Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats.

T. Meert, C. Niemegeers, P. Janssen, 1991, Pharmacopsychiatry.

The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug.

C J Niemegeers, C. Niemegeers, P. Janssen, 1970, European journal of pharmacology.

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?

C J Niemegeers, C. Niemegeers, P. Janssen, 1966, Arzneimittel-Forschung.

The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.

C. Niemegeers, P. Janssen, K. Schellekens, 1970, Arzneimittel-Forschung.

Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone

P. Janssen, K. Schellekens, A. Jageneau, 1959, Psychopharmacologia.

Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. III. Duration of antiemetic action and oral effectiveness of Haloperidol (R 1625) and of chlorpromazine in dogs.

C. Niemegeers, P. Janssen, K. Schellekens, 1960, Arzneimittel-Forschung.